{"id":"non-active-placebo-control","safety":{"commonSideEffects":[{"rate":null,"effect":"Placebo response (symptom improvement without active drug)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo controls are inert formulations used in randomized controlled trials to distinguish the true therapeutic effect of an investigational drug from placebo response, natural disease progression, and observer bias. They allow researchers to measure the magnitude of clinical benefit attributable to the active drug rather than expectation or other non-specific factors.","oneSentence":"A non-active placebo control contains no pharmacologically active ingredients and serves as a comparator in clinical trials to establish baseline efficacy and safety.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:57:36.190Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control comparator (non-therapeutic use)"}]},"trialDetails":[{"nctId":"NCT07485959","phase":"NA","title":"The Effect of NP-2006 on Sleep Quality and Health","status":"COMPLETED","sponsor":"Hanpoong Nature Pharm Co., Ltd.","startDate":"2023-05-12","conditions":"Sleep Disorder (Disorder)","enrollment":48},{"nctId":"NCT05241041","phase":"NA","title":"Effects of Positive Psychological Group Psychotherapy and Auricular Acupressure on Withdrawal Symptoms","status":"COMPLETED","sponsor":"Inha University Hospital","startDate":"2021-09-13","conditions":"Gambling","enrollment":198},{"nctId":"NCT07495254","phase":"NA","title":"Effectiveness of Combined Super Inductive System (SIS) Therapy With Therapeutic Exercise and Health Education in Lateral Elbow Tendinopathy","status":"NOT_YET_RECRUITING","sponsor":"University of Vic - Central University of Catalonia","startDate":"2026-03-30","conditions":"Lateral Epicondylitis (Tennis Elbow), Lateral Epicondylalgia, Lateral Elbow Tendinopathy","enrollment":224},{"nctId":"NCT06072183","phase":"PHASE3","title":"A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2023-11-08","conditions":"Stable Nonsegmental Vitiligo, Active Nonsegmental Vitiligo","enrollment":1571},{"nctId":"NCT07266831","phase":"PHASE2, PHASE3","title":"A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-12-18","conditions":"Human Immunodeficiency Virus Type 1 (HIV-1) Infection","enrollment":570},{"nctId":"NCT04849728","phase":"PHASE3","title":"A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )","status":"ACTIVE_NOT_RECRUITING","sponsor":"Inventiva Pharma","startDate":"2021-08-19","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":1000},{"nctId":"NCT06132256","phase":"PHASE2","title":"MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Syndax Pharmaceuticals","startDate":"2023-12-11","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":145},{"nctId":"NCT06778122","phase":"NA","title":"In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors","status":"RECRUITING","sponsor":"University College, London","startDate":"2026-01-23","conditions":"Cancer Survivors, Cardiotoxicity, Cardiovascular Toxicity Induced by Antitumoral Drugs","enrollment":10},{"nctId":"NCT07398898","phase":"NA","title":"Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients","status":"RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2026-03-01","conditions":"Dental Anxiety, Music Therapy, Oral Surgical Procedures","enrollment":250},{"nctId":"NCT07439666","phase":"NA","title":"NEUROCUPLE™ as an Opioid Alternative Following Total Knee Arthroplasty","status":"NOT_YET_RECRUITING","sponsor":"Jacques E. Chelly","startDate":"2026-03-31","conditions":"Total Knee Arthroplasty Postoperative Pain, Opioid Reduction After TKA","enrollment":274},{"nctId":"NCT04734080","phase":"PHASE4","title":"Dronabinol in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-03-09","conditions":"Total Knee Arthroplasty, Opioid Use","enrollment":114},{"nctId":"NCT07494162","phase":"NA","title":"Imaging Metabolic and Perfusion Changes in Acupuncture Therapy for Myofascial Pain Syndrome","status":"NOT_YET_RECRUITING","sponsor":"University of California, Davis","startDate":"2026-04","conditions":"Myofascial Pain Syndrome (MPS), Chronic Low-back Pain (cLBP)","enrollment":64},{"nctId":"NCT06123754","phase":"PHASE3","title":"Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC","status":"RECRUITING","sponsor":"3D Medicines (Sichuan) Co., Ltd.","startDate":"2023-11-17","conditions":"Non-small Cell Lung Cancer","enrollment":390},{"nctId":"NCT06247345","phase":"PHASE1","title":"A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01","status":"SUSPENDED","sponsor":"Alzheimer's Disease Expert Lab (ADEL), Inc.","startDate":"2024-02-06","conditions":"Alzheimer Disease","enrollment":73},{"nctId":"NCT06969859","phase":"NA","title":"Pulsed Electro-Magnetic Field Therapy for Treatment of Midportion Achilles Tendinopathy","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-10-15","conditions":"Mid-portion Achilles Tendinopathy","enrollment":200},{"nctId":"NCT07311512","phase":"NA","title":"PMPR and Chlorhexidine on Periodontal Disease and Vascular Function","status":"RECRUITING","sponsor":"Mahdi Mutahar","startDate":"2026-01-23","conditions":"Periodontal Disease (PD), Cardio Vascular Disease, Oral-Systemic Link","enrollment":30},{"nctId":"NCT07211958","phase":"PHASE3","title":"Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation","status":"RECRUITING","sponsor":"Syndax Pharmaceuticals","startDate":"2025-11-25","conditions":"Acute Myeloid Leukemias","enrollment":468},{"nctId":"NCT03617679","phase":"PHASE2","title":"Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2019-03-06","conditions":"Metastatic Endometrial Cancer","enrollment":79},{"nctId":"NCT06077760","phase":"PHASE3","title":"A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-12-06","conditions":"Non-small Cell Lung Cancer","enrollment":868},{"nctId":"NCT07448519","phase":"NA","title":"Colonic Delivery of DIM and Perilla Oil on Gut Hormones and Food Intake in Obesity","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2023-06-13","conditions":"Obesity & Overweight, Appetite Regulation","enrollment":20},{"nctId":"NCT06769100","phase":"NA","title":"Exogenous Ketosis and Muscle Protein Synthesis During Exercise Recovery","status":"COMPLETED","sponsor":"McGill University","startDate":"2025-01-10","conditions":"Ketosis, Muscle Protein Synthesis, Dietary Proteins","enrollment":48},{"nctId":"NCT06793397","phase":"PHASE3","title":"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder","status":"RECRUITING","sponsor":"Cybin IRL Limited","startDate":"2025-12-10","conditions":"Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder","enrollment":330},{"nctId":"NCT07176780","phase":"NA","title":"Effect of Semiconductor Embedded Wearable Sleeve on Treatment of Primary Dysmenorrhea Symptoms","status":"NOT_YET_RECRUITING","sponsor":"University of California, Davis","startDate":"2026-05","conditions":"Primary Dysmenorrhea, Primary Dysmenorrhea (PD), Menstrual Cramps","enrollment":100},{"nctId":"NCT05524961","phase":"NA","title":"Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2022-12-09","conditions":"Parkinson Disease","enrollment":69},{"nctId":"NCT07463183","phase":"PHASE2","title":"A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)","status":"NOT_YET_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-03-30","conditions":"Colitis Ulcerative, Ulcerative Colitis","enrollment":100},{"nctId":"NCT06374693","phase":"NA","title":"Investigating the Tolerability and Feasibility of tVNS Following aSAH","status":"RECRUITING","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2024-04-17","conditions":"Subarachnoid Haemorrhage From Cerebral Aneurism Rupture","enrollment":30},{"nctId":"NCT03668041","phase":"PHASE3","title":"National Adaptive Trial for PTSD Related Insomnia","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2021-02-25","conditions":"Insomnia","enrollment":673},{"nctId":"NCT07299019","phase":"PHASE3","title":"A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis","status":"RECRUITING","sponsor":"Zenas BioPharma (USA), LLC","startDate":"2026-03","conditions":"Secondary Progressive Multiple Sclerosis","enrollment":990},{"nctId":"NCT06870409","phase":"PHASE3","title":"Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis","status":"RECRUITING","sponsor":"University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)","startDate":"2025-02-05","conditions":"Endocarditis, Bacterial","enrollment":30},{"nctId":"NCT04944836","phase":"PHASE2","title":"Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-03-09","conditions":"Rotator Cuff Tears","enrollment":58},{"nctId":"NCT05480228","phase":"PHASE2","title":"EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA","status":"COMPLETED","sponsor":"James P. Rathmell, MD","startDate":"2022-09-21","conditions":"Painful Diabetic Neuropathy","enrollment":127},{"nctId":"NCT06994715","phase":"NA","title":"Effects of Acupressure Applied to Intensive Care Patients on Physiological Parameters, Pain, Sleep Quality, Anxiety and Perception of Nursing Presence","status":"COMPLETED","sponsor":"Gazi University","startDate":"2025-05-01","conditions":"Acupressure, Intensive Care Unit, Anxiety","enrollment":60},{"nctId":"NCT01577082","phase":"PHASE3","title":"Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-04-20","conditions":"Asthma","enrollment":542},{"nctId":"NCT04678167","phase":"NA","title":"Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2021-03-10","conditions":"Vestibular Neuritis","enrollment":51},{"nctId":"NCT07303777","phase":"PHASE2","title":"Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis","status":"NOT_YET_RECRUITING","sponsor":"Atom Therapeutics Co., Ltd","startDate":"2026-04","conditions":"Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management","enrollment":200},{"nctId":"NCT07257029","phase":"PHASE2","title":"Topical Ketotifen 0.25% for Secondary Vestibulodynia","status":"RECRUITING","sponsor":"Center for Vulvovaginal Disorders","startDate":"2026-01-02","conditions":"Provoked Vestibulodynia, Secondary Provoked Vestibulodynia, Vulvodynia","enrollment":54},{"nctId":"NCT05604131","phase":"PHASE2","title":"Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients","status":"RECRUITING","sponsor":"Rohan Dharmakumar","startDate":"2022-11-08","conditions":"Acute Myocardial Infarction Type 1","enrollment":89},{"nctId":"NCT03466411","phase":"PHASE2, PHASE3","title":"A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2018-04-13","conditions":"Crohn's Disease","enrollment":1409},{"nctId":"NCT06659029","phase":"","title":"Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-07-01","conditions":"Systemic Lupus Erythematosus","enrollment":442},{"nctId":"NCT05618353","phase":"PHASE4","title":"The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-08-21","conditions":"Coronary Artery Disease","enrollment":700},{"nctId":"NCT07473752","phase":"PHASE1","title":"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects","status":"COMPLETED","sponsor":"Tonix Pharmaceuticals, Inc.","startDate":"2023-07-18","conditions":"Phase 1 First-in-human Study Involving Healthy Subjects","enrollment":26},{"nctId":"NCT07149064","phase":"NA","title":"Effect of Chronic Exposure to Nextida GC-B on Glycemic Control in Adults With Normoglycemia or Prediabetes","status":"RECRUITING","sponsor":"Rousselot BVBA","startDate":"2026-02-18","conditions":"Normoglycemia, Prediabetes, Glycemic Control","enrollment":60},{"nctId":"NCT03947216","phase":"PHASE2","title":"Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.","status":"COMPLETED","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-10-23","conditions":"Parkinson Disease","enrollment":117},{"nctId":"NCT06807424","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-01-09","conditions":"Arthritis, Psoriatic","enrollment":750},{"nctId":"NCT04118387","phase":"PHASE4","title":"Central Sleep Apnea : Physiologic Mechanisms to Inform Treatment","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2021-01-07","conditions":"Sleep Disordered Breathing, Able Bodied","enrollment":200},{"nctId":"NCT07284979","phase":"PHASE3","title":"Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes","status":"RECRUITING","sponsor":"Kailera","startDate":"2025-12-30","conditions":"Obesity","enrollment":1200},{"nctId":"NCT04882098","phase":"PHASE3","title":"A Study of Guselkumab in Participants With Active Psoriatic Arthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2021-06-17","conditions":"Arthritis, Psoriatic","enrollment":1054},{"nctId":"NCT07196722","phase":"PHASE2, PHASE3","title":"A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-10-03","conditions":"Crohn Disease","enrollment":1092},{"nctId":"NCT03451851","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2018-07-11","conditions":"Psoriasis","enrollment":120},{"nctId":"NCT04798274","phase":"NA","title":"Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder","status":"RECRUITING","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2021-06-15","conditions":"Autism Spectrum Disorder","enrollment":106},{"nctId":"NCT07468591","phase":"NA","title":"Spinal Cord Stimulation for Refractory Pain Randomized Controlled Trial: the PAcStim RCT","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-04-01","conditions":"Chronic Pain Syndrome","enrollment":90},{"nctId":"NCT06720909","phase":"NA","title":"Mindfulness And Placebo for Pain (MAPP) Study","status":"RECRUITING","sponsor":"Arizona State University","startDate":"2025-01-27","conditions":"Chronic Pain","enrollment":45},{"nctId":"NCT07052890","phase":"NA","title":"Curcumin, Vitamin D and Green Tea in IBS-D","status":"COMPLETED","sponsor":"Dr Anthony Hobson","startDate":"2024-09-19","conditions":"Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome With Diarrhea (IBS-D)","enrollment":78},{"nctId":"NCT06132581","phase":"NA","title":"Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression","status":"RECRUITING","sponsor":"Florida State University","startDate":"2024-01-24","conditions":"Major Depressive Disorder, Anhedonia","enrollment":72},{"nctId":"NCT06853262","phase":"NA","title":"Manual Therapy in Parkinson's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of La Laguna","startDate":"2024-04-01","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT05901571","phase":"NA","title":"Acupuncture and Escitalopram for Treating Major Depression Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Shanghai 7th People's Hospital","startDate":"2026-11","conditions":"Depressive Disorder, Major","enrollment":216},{"nctId":"NCT06453980","phase":"NA","title":"Multimodal Investigation of Neural Plasticity","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2024-05-13","conditions":"Mild Cognitive Impairment","enrollment":80},{"nctId":"NCT07214974","phase":"EARLY_PHASE1","title":"Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.","status":"NOT_YET_RECRUITING","sponsor":"Noah Tech, Corp.","startDate":"2026-09-01","conditions":"Mild Cognitive Impairment (MCI), Early Stages of Cognitive Decline, Alzheimer's Disease Dementia","enrollment":600},{"nctId":"NCT07459231","phase":"NA","title":"The Effect of Kinesio Taping During Labor on Low Back Pain, Vaginal Birth Self-Efficacy, Postpartum Comfort Perception, and Newborn Apgar Scores","status":"COMPLETED","sponsor":"Ege University","startDate":"2025-07-20","conditions":"Low Back Pain, Pregnancy, Midwifery","enrollment":75},{"nctId":"NCT07461506","phase":"NA","title":"NeuroCuple to Mitigate Post-Wisdom Teeth Extraction Opioid Risks","status":"NOT_YET_RECRUITING","sponsor":"nCap Medical","startDate":"2026-06-30","conditions":"Wisdom Teeth, Wisdom Teeth Extraction or Jaw Implant","enrollment":120},{"nctId":"NCT07460895","phase":"NA","title":"Effectiveness of Photobiomodulation for Myofascial Pain in Temporomandibular Disorders","status":"NOT_YET_RECRUITING","sponsor":"Federal University of Rio Grande do Sul","startDate":"2026-03-10","conditions":"Photobiomodulation, Temporomandibular Disorder (TMD), Myofacial Pain","enrollment":140},{"nctId":"NCT07461363","phase":"NA","title":"Efficacy of Low-Dose Laser Acupuncture for Low Back Pain","status":"ENROLLING_BY_INVITATION","sponsor":"Mun Fei Yam","startDate":"2025-11-01","conditions":"Chronic Low Back Pain","enrollment":80},{"nctId":"NCT07461220","phase":"PHASE1, PHASE2","title":"Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy","status":"RECRUITING","sponsor":"Integrative Research Laboratories AB","startDate":"2026-02-18","conditions":"PARKINSON DISEASE (Disorder), Apathy, Safety","enrollment":75},{"nctId":"NCT07249554","phase":"PHASE2","title":"Combination Therapy for Alcohol Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-05","conditions":"Alcohol Use Disorder","enrollment":45},{"nctId":"NCT07437222","phase":"NA","title":"Effect of Ginger Capsules on Inflammation, Oxidative Stress, and Endothelial Function","status":"RECRUITING","sponsor":"Ana Mª Garcia Munoz","startDate":"2026-03-02","conditions":"Inflammation Biomarkers, Oxidative Stress, Cardiometabolic Risk Factors","enrollment":50},{"nctId":"NCT04722354","phase":"PHASE2","title":"Abscisic Acid Effects on Glucose Homeostasis and Insulin Sensitivity","status":"COMPLETED","sponsor":"AdventHealth Translational Research Institute","startDate":"2021-03-08","conditions":"Pre Diabetes","enrollment":5},{"nctId":"NCT06671483","phase":"PHASE3","title":"A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-03-03","conditions":"Psoriatic Arthritis","enrollment":1088},{"nctId":"NCT07444996","phase":"NA","title":"Effect of Magnetotherapy Combined With Cold Application and Exercise in Patients With Lateral Epicondylitis","status":"NOT_YET_RECRUITING","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2026-02-27","conditions":"Magnetotherapy, Lateral Epicondylitis (Tennis Elbow)","enrollment":40},{"nctId":"NCT06671496","phase":"PHASE3","title":"A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-03-10","conditions":"Psoriatic Arthritis","enrollment":600},{"nctId":"NCT04404153","phase":"NA","title":"Neurostimulation for Cognitive Enhancement in Alzheimer's Disease","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2021-03-25","conditions":"Alzheimer Disease, Dementia","enrollment":100},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT05503264","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-09-27","conditions":"NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis","enrollment":152},{"nctId":"NCT07339280","phase":"NA","title":"Probiotics in COPD: Effects on Symptoms, Lung Function, and Inflammation","status":"ENROLLING_BY_INVITATION","sponsor":"University Hospital of Split","startDate":"2026-03","conditions":"COPD, COPD (Chronic Obstructive Pulmonary Disease), Probiotic","enrollment":60},{"nctId":"NCT07298395","phase":"PHASE2","title":"Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis","status":"RECRUITING","sponsor":"Enveda Therapeutics","startDate":"2025-12-22","conditions":"Atopic Dermatitis (AD)","enrollment":64},{"nctId":"NCT05342519","phase":"PHASE2","title":"Daily Topical Rapamycin for Vitiligo","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2022-07-28","conditions":"Vitiligo","enrollment":20},{"nctId":"NCT07301255","phase":"PHASE2","title":"ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults","status":"RECRUITING","sponsor":"Enveda Therapeutics","startDate":"2026-01-09","conditions":"Asthma","enrollment":50},{"nctId":"NCT03319498","phase":"NA","title":"Postpartum Urinary Retention With Essential Oils (PURE)","status":"TERMINATED","sponsor":"Mount Carmel Health System","startDate":"2018-01-01","conditions":"Urinary Retention","enrollment":77},{"nctId":"NCT07449117","phase":"NA","title":"Effect of Striatal Temporal Interference Stimulation on Language Processing in Neurodegenerative Diseases","status":"RECRUITING","sponsor":"Masaryk University","startDate":"2026-03","conditions":"Mild Cognitive Impairment (MCI) Amnestic, Lewy Body Disease With Mild Cognitive Impairment, Parkinson's Disease With Mild Cognitive Impairment","enrollment":70},{"nctId":"NCT07379580","phase":"PHASE2","title":"A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2026-02-20","conditions":"Mpox (Monkeypox), Smallpox, Orthopoxvirus Infection","enrollment":310},{"nctId":"NCT05224063","phase":"NA","title":"Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression","status":"COMPLETED","sponsor":"Stanford University","startDate":"2023-01-01","conditions":"Major Depressive Disorder","enrollment":50},{"nctId":"NCT05889182","phase":"PHASE3","title":"A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy","status":"RECRUITING","sponsor":"AbbVie","startDate":"2023-06-21","conditions":"Hidradenitis Suppurativa","enrollment":1328},{"nctId":"NCT07445568","phase":"NA","title":"Home-Based Quadriceps Isometric Exercise for Knee Osteoarthritis Pain","status":"COMPLETED","sponsor":"Universidad del Valle de México, Campus Cuernavaca","startDate":"2025-09-01","conditions":"Older Adults (60 - 85 Years Old), OA Knee","enrollment":50},{"nctId":"NCT06278077","phase":"PHASE2","title":"Neurexan - a Clinical Trial in Short-Term Insomnia Patients","status":"COMPLETED","sponsor":"Biologische Heilmittel Heel GmbH","startDate":"2023-09-06","conditions":"Insomnia, Stress Reaction","enrollment":81},{"nctId":"NCT07186101","phase":"PHASE2","title":"LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-11-11","conditions":"Ulcerative Colitis","enrollment":252},{"nctId":"NCT07318480","phase":"NA","title":"Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2026-02-25","conditions":"Cocaine Use Disorder, Cocaine Dependence, Substance Use Disorder (SUD)","enrollment":120},{"nctId":"NCT06379074","phase":"NA","title":"Poor Sleep During Pregnancy as Risk Factor for Post-partum Stress and Mental Health","status":"RECRUITING","sponsor":"University of Rome G. Marconi","startDate":"2024-05-06","conditions":"Postpartum Depression, Insomnia, Stress","enrollment":114},{"nctId":"NCT05175105","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension Period","status":"ACTIVE_NOT_RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2022-06-06","conditions":"Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia","enrollment":30},{"nctId":"NCT05869812","phase":"PHASE2","title":"Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-05-29","conditions":"Atrophy","enrollment":30},{"nctId":"NCT06563895","phase":"PHASE3","title":"Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant","status":"RECRUITING","sponsor":"Eidos Therapeutics, a BridgeBio company","startDate":"2025-05-12","conditions":"Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis","enrollment":582},{"nctId":"NCT07444242","phase":"NA","title":"Accelerated Treatment of Depressive Patients With tDCS","status":"NOT_YET_RECRUITING","sponsor":"University of Regensburg","startDate":"2026-03-16","conditions":"Major Depressive Disorder","enrollment":30},{"nctId":"NCT07442786","phase":"NA","title":"Clustered tDCS Sessions for Reducing Alcohol Consumption in Non-abstinent Patients With Alcohol Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2026-04","conditions":"Chronic Alcohol Use Disorder","enrollment":312},{"nctId":"NCT07441421","phase":"NA","title":"Perioperative Multimodal Analgesia for Supratentorial Craniotomy","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-01","conditions":"Postoperative Pain, Analgesia, Supratentorial Brain Tumor","enrollment":2000},{"nctId":"NCT06335823","phase":"NA","title":"Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2024-06-05","conditions":"IUD Insertion Pain","enrollment":60},{"nctId":"NCT04115033","phase":"NA","title":"Randomized Controlled Trial of CES for Fibromyalgia","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2020-03-02","conditions":"Fibromyalgia","enrollment":50},{"nctId":"NCT05583526","phase":"PHASE3","title":"A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo","status":"COMPLETED","sponsor":"Pfizer","startDate":"2022-12-01","conditions":"Stable Nonsegmental Vitiligo, Active Nonsegmental Vitiligo","enrollment":607},{"nctId":"NCT07435129","phase":"PHASE2","title":"Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD","status":"NOT_YET_RECRUITING","sponsor":"Scholar Rock, Inc.","startDate":"2026-08","conditions":"Facioscapulohumeral Muscular Dystrophy, FSHD","enrollment":60},{"nctId":"NCT07232069","phase":"PHASE3","title":"PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-07-01","conditions":"Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression, Prevention & Control","enrollment":1500},{"nctId":"NCT07435961","phase":"NA","title":"Magnetotherapy in Carpal Tunnel Syndrome: Randomized Controlled Study","status":"NOT_YET_RECRUITING","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2026-02-01","conditions":"Magnetotherapy, Carpal Tunnel Syndrome (CTS), Median Nerve Compression","enrollment":60},{"nctId":"NCT07247721","phase":"NA","title":"Transcutaneous vs Percutaneous Electrical Stimulation of the Radial Nerve","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Castilla-La Mancha","startDate":"2026-01-15","conditions":"Pain Modulation, Sensorimotor Function, Nerve Stimulation","enrollment":120},{"nctId":"NCT04851301","phase":"PHASE1, PHASE2","title":"Neural Mechanisms of Immersive Virtual Reality in Chronic Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2021-11-01","conditions":"Pain, Virtual Reality, Placebo","enrollment":259}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Non-active placebo control","genericName":"Non-active placebo control","companyName":"The Center for Clinical and Cosmetic Research","companyId":"the-center-for-clinical-and-cosmetic-research","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tinlarebant is a small molecule being studied in clinical trials for various conditions, including Stargardt Disease 1, Schizophrenia, Non Small Cell Lung Cancer, Primary Hyperoxaluria, and Asthma. In at least one clinical trial, a placebo control is used to compare the safety and efficacy of tinlarebant to a non-treatment option.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}